We are still in process of gathering more medical related information for this page. In the meantime, here are some links that we thought might be quite helpful:

Websites:
The New England Journal of Medicine
1. ADHD Drugs and Cardiovascular Risk
2. Genetics of Developmental Disabilities
3. Is Our Behavior Written in Our Genes?

Articles for Download:

2006
1. Autism, Asperger Syndrome And Brain Mechanisms For The Attribution Of Mental States To Animated Shapes
2. Evidence From A Family History Study Of Multiple Incidence Autism Families
3. A Modified Screening Tool For Autism For Chinese Children
4.
ADHD Drugs and Cardiovascular Risk
5. Regression in Pervasive Developmental Disorders

2007
[* updated 12.9.07]
1. A pilot evaluation of the safety, tolerability and effectiveness of memantine in children wiuth ADD-HD disorder
2. A prospective open-label trial of memantine in treatment of congnitive, behavioral and memoray dysfunction in PDD
3. Diagnosis & Management of Cough Executive Summary
4. Efficacy & Safety of NRP104 in children aged 6-12 years with ADHD
5. FDA approves new ADHD treatment with lower abuse potential
6. FDA ask ADHD drug manufacturers to develop patient medication guides
7. FDA directs ADHD drug manufacturer to notify patients about cardiovascular adverse & psychiatric adverse events
8. FDA warning of Xolair for ADHD
9. FDA's Warning Against Cough Medicine to Children Under 2
10. Medication use among children with autism spectrum [J Child Adolesc Psychopharmacol 2007] - PubMed
11. Memantine an adjunctive theraphy in children with ASD
12. Parent-assisted friendship training for children with ASD [Child Psychiatry Hum Dev_ 2007] - PubMed
13. Parent-Rated Anxiety Symptoms in Children with PDD [J Abnorm Child Psychol_ 2007] - PubMed
14. Parents Urged to Protect Preteens - August 1, 2007
15. Psychopharmacology of autistic disorders-Z Kinder Jugendpsychiatr Psychother 2007] - PubMed
16. Soft Drinks-Metabollic Syndrome
17. TV Viewing Link with Learning Disabilities
18. 3 year followup of a child psychiatric cohort
*
19. A Study-Impact of comorbid ASD on stimulant response in children with ADHD
*
20. Are there enchanced MBP autoantibodies in autism?
*
21. Children with ASD & intellectual disability
*
22. Clinical effects & adverse reactions of aripiprazole in children & adolescents with developmental disabilities
*
23. Development of real time internet based system for monitoring pharmacological interventions in children with neurodevelopmental & neuropsychiatric disorders
*
24. Drug therapy for ADHD like symptoms in autistic disorder
*
25. Fragile X syndrome-assessment & treatment implications
*
26. Good practice guidelines for treatment of ASD
*
27. Health care expenditures associated with ASD
*
28. Medical management of autism
*
29. Medication use among children with ASD
*
30. Mercury exposure and public health
*
31. Music Therapy in assessment & treatment of ASD
*
32. Neorobiological effects of intraventricular propionic acid in rats-possible role of short chain fatty acid on pathogenesis & characteristics of ASD
*
33. Neurofeedback-train your brain to train behaviour
*
34. Open label atomoxetine for ADHD symptoms associated with high functioning PDD
*
35. Orienting to social stomuli differentiates social cognitive impairment in autism and schizophrenia
*
36. Pilot study for problematic children with autism
*
37. Post-error adaptation in adults with high functioning autism
*
38. Prospective open label trial of galantamine in austic disorder
*
39. Psychopathology in adults with autism and intellectual disability
*
40. Recommended Immunization Schedule for Persons aged 0-18 years
*
41. Risperidone for ASD
*
42. Survey of atypical antipsychotic for patients aged under 18 for PDD-PubMed
*
43. Underdiagnosis of Hypertension in Children
*
44. Vaccination amoung young children & adolscents
*
45. Vaccines & changing epidemiology of autism
*







© 2004 by Early Intervention Programme - Autism Sdn. Bhd. All rights reserved.
No part of the information contained herein may be reproduced or transmitted in any form or by any means, electronic or otherwise,including photocopy, or any information storage and retrieval system without written permission.